Evidence map›Paper›PMID 38178245›Full record

ArticleGut pathogens2024

Temporal changes in the positivity rate of common enteric viruses among paediatric admissions in coastal Kenya, during the COVID-19 pandemic, 2019-2022.

Arnold W Lambisia, Nickson Murunga, Martin Mutunga, Robinson Cheruiyot, Grace Maina, Timothy O Makori, D James Nokes, Charles N Agoti

Abstract read
In one paragraph

Article in Gut pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arnold W LambisiaKenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), P.O. Box 230, Kilifi, 80108, Kenya. alambisia@kemri-wellcome.org.
Nickson MurungaKenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), P.O. Box 230, Kilifi, 80108, Kenya.
Martin MutungaKenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), P.O. Box 230, Kilifi, 80108, Kenya.
Robinson CheruiyotKenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), P.O. Box 230, Kilifi, 80108, Kenya.
Grace MainaKenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), P.O. Box 230, Kilifi, 80108, Kenya.
Timothy O MakoriKenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), P.O. Box 230, Kilifi, 80108, Kenya.
D James NokesKenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), P.O. Box 230, Kilifi, 80108, Kenya.
Charles N AgotiKenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), P.O. Box 230, Kilifi, 80108, Kenya.

Funding

EPA EP-C-15-003Wellcome TrustWellcome Trust 102975
6 · The paper itself

Abstract

backgroundThe non-pharmaceutical interventions (NPIs) implemented to curb the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early in the coronavirus disease 2019 (COVID-19) pandemic, substantially disrupted the activity of other respiratory viruses. However, there is limited data from low-and-middle income countries (LMICs) to determine whether these NPIs also impacted the transmission of common enteric viruses. Here, we investigated the changes in the positivity rate of five enteric viruses among hospitalised children who presented with diarrhoea to a referral hospital in coastal Kenya, during COVID-19 pandemic period.

methodsA total of 870 stool samples from children under 13 years of age admitted to Kilifi County Hospital between January 2019, and December 2022 were screened for rotavirus group A (RVA), norovirus genogroup II (GII), astrovirus, sapovirus, and adenovirus type F40/41 using real-time reverse-transcription polymerase chain reaction. The proportions positive across the four years were compared using the chi-squared test statistic.

resultsOne or more of the five virus targets were detected in 282 (32.4%) cases. A reduction in the positivity rate of RVA cases was observed from 2019 (12.1%, 95% confidence interval (CI) 8.7-16.2%) to 2020 (1.7%, 95% CI 0.2-6.0%; p < 0.001). However, in the 2022, RVA positivity rate rebounded to 23.5% (95% CI 18.2%-29.4%). For norovirus GII, the positivity rate fluctuated over the four years with its highest positivity rate observed in 2020 (16.2%; 95% C.I, 10.0-24.1%). No astrovirus cases were detected in 2020 and 2021, but the positivity rate in 2022 was similar to that in 2019 (3.1% (95% CI 1.5%-5.7%) vs. 3.3% (95% CI 1.4-6.5%)). A higher case fatality rate was observed in 2021 (9.0%) compared to the 2019 (3.2%), 2020 (6.8%) and 2022 (2.1%) (p < 0.001).

conclusionOur study finds that in 2020 the transmission of common enteric viruses, especially RVA and astrovirus, in Kilifi Kenya may have been disrupted due to the COVID-19 NPIs. After 2020, local enteric virus transmission patterns appeared to return to pre-pandemic levels coinciding with the removal of most of the government COVID-19 NPIs.

Indexed as

Adenovirus F40/41AstrovirusCOVID-19KenyaNorovirus GIIPaediatricsPositivity rateRotavirus group ASapovirus

Identifiers

PMID38178245
PMCPMC10765698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.